Catheryn D. Wilson

Characterization of structurally novel G protein biased CB 1 agonists: Implications for drug development

Benjamin M. Ford, Lirit N. Franks, Sherrica Tai et al. · Pharmacological Research · 2017 · 40 citations · Full text

Cannabis Use, Molecular Pharmacology, Drug Target +10

Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice

Catheryn D. Wilson, Sherrica Tai, Laura Ewing et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 24 citations · Full text

In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome

Bryce A. Griffin, Caitlin Caperton, Lauren Russell et al. · Journal of Pharmacology and Experimental Therapeutics · 2019 · 23 citations · Full text

The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice

Molly S. Crowe, Catheryn D. Wilson, Emma Leishman et al. · British Journal of Pharmacology · 2017 · 21 citations · Full text

Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ9-THC

Rachel D. Hutchison, Benjamin M. Ford, Lirit N. Franks et al. · Frontiers in Pharmacology · 2018 · 21 citations · Full text